Travel + Leisure on MSN18d
Banff National Park Is Magical in the Winter With Skiing, Frozen Waterfalls, and Castle Hotels—Here's How to Plan a VisitBut Banff National Park wasn’t just about stunning landscapes—it was a journey of firsts, challenges, and personal discoveries. (My first time in this winter wonderland entail ...
Travel + Leisure on MSN12d
This Hotel in the Swiss Alps Is Near Europe's Highest Suspension Bridge, and It Has a Rooftop Infinity Pool With Stunning Mountain ViewsThe 49-foot rooftop infinity pool runs alongside the spa's floor-to-ceiling windows, offering uninterrupted views of Titlis ...
Detroit Lakes (basement of the Holmes Theatre), starting at 10 a.m. Chase, the author of "In Spite of Heroin" (available locally at Bluebird Books ... 6:30-9 p.m.; Karaoke with Baity Boys Get ...
Detroit Lakes (basement of the Holmes Theatre), starting at 10 a.m. Chase, the author of "In Spite of Heroin" (available locally at Bluebird Books ... 8 p.m.-12:30 a.m.; Karaoke with Baity ...
bluebird stockholders to receive $3.00 per share in cash and a contingent value right of $6.84 per share in cash payable upon achievement of a net sales milestone, contingent upon offer conditions ...
Flying high as one of the world’s premier developers of gene therapies in early 2018, bluebird bio’s share price hit a dizzying $2,300 apiece. But seven years later—after failing to build a ...
Bluebird bio will be acquired by investment firms Carlyle and SK Capital Partners, marking the end to its turbulent time as a publicly traded company. The agreement comes after years of financial ...
Cash-strapped gene-therapy company Bluebird bio agreed to be acquired by private-equity firms Carlyle Group and SK Capital Partners in a deal potentially worth up to $96 million. Bluebird on ...
Shares of bluebird bio (NASDAQ:BLUE) continued their downward descent Monday in the wake of news that the company has agreed to be taken private by Carlyle Group (NASDAQ:CG) and SK Capital ...
For a full version of this story, visit STAT. Bluebird Bio announced Friday it would sell itself and its portfolio of gene therapies to the investment firms Carlyle and SK Capital for less than $ ...
Bluebird Bio announced Friday it would sell itself and its portfolio of gene therapies to the investment firms Carlyle and SK Capital for less than $30 million, in a deal that lets the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback